LAUSR

Abstract Combined heart-liver transplant (CHLTx) remains the only option for long-term survival in patients with end-stage heart and hepatic failure. To date, there are a limited number of transplant centers in the United States that have conducted a CHLTx. Between July of 2009 and December 2019, our group has performed the largest series (N=20) of en bloc CHLTx to date. En block combined heart-liver transplantation offers both grafts the opportunity to minimize dysfunction with shorter ischemic time compared to sequential heart-liver transplant. This technique simplifies the surgery in patients with complex venous anatomy such as heterotaxy patients and can be performed in dextrocardia or levocardia patients, irrespective of the side of IVC or SVC. We describe our indications and detailed en-block technique for combined heart-liver with its midterm outcome.